Predicting RTS,S Vaccine-Mediated Protection from Transcriptomes in a Malaria-Challenge Clinical Trial.

Area of Science:

• Immunology
• Vaccinology
• Genomics

Background:

• The RTS,S malaria vaccine demonstrates efficacy against malaria but its precise mechanism of protection is not fully understood.
• Investigating the molecular and immunological underpinnings of vaccine-induced immunity is crucial for further vaccine development.

Purpose of the Study:

• To elucidate the mechanisms of protection conferred by the RTS,S malaria vaccine.
• To identify key immune pathways and gene expression signatures associated with RTS,S vaccine efficacy.

Main Methods:

• Analysis of longitudinal peripheral blood transcriptome and immunogenicity data from a clinical trial involving RTS,S vaccination followed by controlled human malaria infection (CHMI).
• Application of Multiway Partial Least Squares Discriminant Analysis (N-PLS-DA) to identify predictive gene signatures.
• Correlation analysis of serum interferon-gamma (IFN-γ) concentrations with protection.

Main Results:

• A set of 110 genes predictive of protection was identified using N-PLS-DA of transcriptome data.
• Among these, 42 genes were linked to immune functions, notably 29 in the NF-κB signaling pathway and 14 in the IFN-γ signaling pathway.
• Serum IFN-γ concentrations post-vaccination correlated with protection, and IFN-γ pathway genes were highly represented in predictive models.

Conclusions:

• The findings suggest that the RTS,S vaccine-induced protection involves the activation of NF-κB and IFN-γ signaling pathways.
• This research provides valuable insights into the molecular mechanisms underlying RTS,S vaccine efficacy, potentially guiding future malaria vaccine design.